The END-VOC Consortium Holds its Final General Assembly Meeting in Lisbon
Project partners showcased major achievements and ongoing work including data harmonisation, long Covid burden, and policy recommendations to support future pandemic responses […]
The ENDVOC Consortium Calls for Funding, Research and Awareness on Long Covid and Other Post-Acute Infection Syndromes
A recently published document provides a timely update on the epidemiology, burden and policy actions on Long Covid […]
ENDVOC Study Finds Stronger Immune Response to SARS-CoV-2 Infection in People with Long COVID
The study, based on a population cohort in England, measured levels of antibodies to the SARS-CoV-2 virus […]
COVID-19 Vaccination Induces Long-Lasting Antibody B-cell Responses
END-VOC researchers followed a cohort of healthcare workers in Catalonia during three years […]
A Switch to IgG4 Antibodies After COVID-19 Vaccination May Increase the Risk of Breakthrough Infections
For over three years, ENDVOC researchers analysed the quantity and function of different antibody classes in a cohort of healthcare workers who received mRNA vaccine booster doses […]
